<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00494169</url>
  </required_header>
  <id_info>
    <org_study_id>U54HD028138</org_study_id>
    <nct_id>NCT00494169</nct_id>
  </id_info>
  <brief_title>Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders</brief_title>
  <official_title>Molecular Basis of Inherited Reproductive Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are: 1) to identify genes that play a role in human pubertal
      development and reproduction, 2) to characterize the phenotypic spectrum of patients with
      these gene defects, and 3) to discern the mode of inheritance for disorders caused by these
      gene defects. We are specifically interested in genes that cause Kallmann syndrome,
      idiopathic hypogonadotropic hypogonadism (IHH), precocious (early) puberty, and delayed
      puberty. Individuals do not have to travel to Boston to participate in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overview:

      Our work is divided into two main areas of investigation:

        1. the discovery of new, yet-undiscovered genes for conditions of early (i.e. precocious)
           puberty, delayed puberty, absence of pubertal development (i.e. Kallmann syndrome) as
           well as normal puberty that is accompanied by an altered reproductive system later in
           life (i.e. hypothalamic amenorrhea in women or very low testosterone levels in men).
           Identification of new genes requires either a single large family or a collection of
           smaller families.

        2. a detailed examination of the genes already implicated in causing these conditions.

      There are several other important aspects about our program:

        -  This analysis will detect DNA abnormalities only in those DNA segments being screened.
           The turnaround time to process a sample is approximately 6-9 months. We must receive a
           signed consent form in order to begin analysis on a blood sample.

        -  Our laboratory is located in Massachusetts General Hospital, Boston MA and is largely
           funded by the National Institutes of Health. We are a research laboratory and not a CLIA
           certified clinical laboratory.

        -  Even if a patient is the only member of his/her family affected by one of the conditions
           mentioned above, obtaining blood samples on other family members, including parents and
           siblings is often important to our work.

        -  It is every individual's responsibility to notify the research team he/she would like to
           obtain research results. The patient must sign a second consent form before receiving
           such information.

      Study Procedures and Risks

        -  You will be asked to give approximately 3-5 tablespoons of blood for this research
           project. There is a risk of bruising and a very small amount of bleeding associated with
           blood drawing.

        -  You will be asked to fill out a medical history checklist, indicating the presence or
           absence of clinical features that may be associated with abnormalities in pubertal
           development.

        -  Since absence of puberty is sometimes associated with limited or no smell ability, you
           may be asked to try to identify the odors in a scratch and sniff test. This will take
           about 15 minutes.

        -  Your family history can give us clues to determine how your condition was inherited.
           Therefore, a detailed family history, at least back to your grandparents will be
           obtained by a researcher.

      Benefits:

      There are no direct benefits to you from participation in this study. Some genes for this
      condition are known, other genes have yet to be discovered. If this study discovers what
      genes are responsible, it will help to further the understanding of this disorder. It is
      possible that the genetic cause of your reproductive disorder may be learned. This
      information can be shared with you at your request.

      When contacting us, please include in your message a description of your diagnosis, your
      pubertal history (age when you hit pubertal hallmarks, e.g., growth spurt; body hair; voice
      deepening and genital growth for men; menstruation and breast development for women) and your
      reproductive history.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 1999</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of DNA abnormalities</measure>
    <time_frame>5/2015</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Hypogonadism</condition>
  <condition>Kallmann Syndrome</condition>
  <condition>Puberty, Delayed</condition>
  <condition>Puberty, Precocious</condition>
  <condition>Hypothalamic Amenorrhea</condition>
  <condition>Anosmia</condition>
  <condition>GnRH Deficiency</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      WBC are transformed into immortalized cell lines.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who

          1. fail to go through a normal, age-appropriate, spontaneous puberty, and abnormal
             hormone levels.

          2. have abnormally early development of puberty (Precocious Puberty) OR

          3. display low gonadotropins in adulthood after having gone through normal pubertal
             development.

        Family members of these patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Failure to go through a normal, age-appropriate, spontaneous puberty, and abnormal
             hormone levels.

          -  Children with abnormally early development of puberty (Precocious Puberty)

          -  Adults who display low gonadotropins in adulthood after having gone through normal
             pubertal development.

          -  Family members of these patients.

        Exclusion Criteria:

          -  pituitary tumor

          -  high prolactin levels
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William F Crowley, Jr., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ravi Balasubramanian, MD, PhD</last_name>
    <phone>617-726-8432</phone>
    <email>ReproEndoGenetics@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathryn Salnikov, BS</last_name>
    <phone>617-726-1309</phone>
    <email>ksalnikov@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Salnikov, BS</last_name>
      <phone>617-726-1309</phone>
      <email>ksalnikov@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ravi Balasubramanian, MD, PhD</last_name>
      <phone>617-726-8432</phone>
      <email>ReproEndoGenetics@partners.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.massgeneral.org/reproendo/pages/reu_study_subject.htm</url>
    <description>Clinical research studies of the Reproductive Endocrine Unit at the Massachusetts General Hospital. Click here for more information about this study: Molecular Basis of Inherited Reproductive Disorders</description>
  </link>
  <reference>
    <citation>Kallmann FJ, Schoenfeld WA. The genetic aspects of primary eunuchoidism. American Journal of Mental Deficiency 158:203-236, 1944.</citation>
  </reference>
  <reference>
    <citation>Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, Brown CJ, Willard HF, Lawrence C, Graziella Persico M, Camerino G, Ballabio A. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature. 1991 Oct 10;353(6344):529-36.</citation>
    <PMID>1922361</PMID>
  </reference>
  <reference>
    <citation>Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell. 1991 Oct 18;67(2):423-35.</citation>
    <PMID>1913827</PMID>
  </reference>
  <reference>
    <citation>Burris TP, Guo W, McCabe ER. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the superfamily. Recent Prog Horm Res. 1996;51:241-59; discussion 259-60. Review.</citation>
    <PMID>8701082</PMID>
  </reference>
  <reference>
    <citation>de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med. 1997 Nov 27;337(22):1597-602.</citation>
    <PMID>9371856</PMID>
  </reference>
  <reference>
    <citation>Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet. 1998 Jan;18(1):14-5.</citation>
    <PMID>9425890</PMID>
  </reference>
  <reference>
    <citation>Crowley WF Jr, Pitteloud N, Seminara S. New genes controlling human reproduction and how you find them. Trans Am Clin Climatol Assoc. 2008;119:29-37; discussion 37-8. Review.</citation>
    <PMID>18596868</PMID>
  </reference>
  <reference>
    <citation>Balasubramanian R, Plummer L, Sidis Y, Pitteloud N, Martin C, Zhou QY, Crowley WF Jr. The puzzles of the prokineticin 2 pathway in human reproduction. Mol Cell Endocrinol. 2011 Oct 22;346(1-2):44-50. doi: 10.1016/j.mce.2011.05.040. Epub 2011 Jun 1. Review.</citation>
    <PMID>21664414</PMID>
  </reference>
  <reference>
    <citation>Au MG, Crowley WF Jr, Buck CL. Genetic counseling for isolated GnRH deficiency. Mol Cell Endocrinol. 2011 Oct 22;346(1-2):102-9. doi: 10.1016/j.mce.2011.05.041. Epub 2011 Jun 1. Review.</citation>
    <PMID>21664415</PMID>
  </reference>
  <results_reference>
    <citation>Pitteloud N, Meysing A, Quinton R, Acierno JS Jr, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley WF Jr. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol. 2006 Jul 25;254-255:60-9. Epub 2006 Jun 9.</citation>
    <PMID>16764984</PMID>
  </results_reference>
  <results_reference>
    <citation>Pallais JC, Bo-Abbas Y, Pitteloud N, Crowley WF Jr, Seminara SB. Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54. Mol Cell Endocrinol. 2006 Jul 25;254-255:70-7. Epub 2006 Jun 6.</citation>
    <PMID>16757106</PMID>
  </results_reference>
  <results_reference>
    <citation>Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley WF Jr. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6281-6. Epub 2006 Apr 10.</citation>
    <PMID>16606836</PMID>
  </results_reference>
  <results_reference>
    <citation>Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ, Crowley WF Jr. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab. 2005 Mar;90(3):1317-22. Epub 2004 Dec 21.</citation>
    <PMID>15613419</PMID>
  </results_reference>
  <results_reference>
    <citation>Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008 Feb 14;358(7):709-15. doi: 10.1056/NEJMoa073443.</citation>
    <PMID>18272894</PMID>
  </results_reference>
  <results_reference>
    <citation>Cerrato F, Seminara SB. Human genetics of GPR54. Rev Endocr Metab Disord. 2007 Mar;8(1):47-55. Review.</citation>
    <PMID>17334928</PMID>
  </results_reference>
  <results_reference>
    <citation>Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, Cole LW, Plummer L, Jacobson-Dickman EE, Mellon PL, Zhou QY, Crowley WF Jr. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17447-52. Epub 2007 Oct 24.</citation>
    <PMID>17959774</PMID>
  </results_reference>
  <results_reference>
    <citation>Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, Van Vliet G, Bouloux P, Hall JE, Hayes FJ, Pitteloud N, Martin KA, Welt C, Seminara SB. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol. 2006 Nov;155 Suppl 1:S3-S10.</citation>
    <PMID>17074994</PMID>
  </results_reference>
  <results_reference>
    <citation>Bo-Abbas Y, Acierno JS Jr, Shagoury JK, Crowley WF Jr, Seminara SB. Autosomal recessive idiopathic hypogonadotropic hypogonadism: genetic analysis excludes mutations in the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes. J Clin Endocrinol Metab. 2003 Jun;88(6):2730-7.</citation>
    <PMID>12788881</PMID>
  </results_reference>
  <results_reference>
    <citation>Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003 Oct 23;349(17):1614-27.</citation>
    <PMID>14573733</PMID>
  </results_reference>
  <results_reference>
    <citation>Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. Clin Genet. 2009 Jan;75(1):65-71. doi: 10.1111/j.1399-0004.2008.01107.x. Epub 2008 Nov 17.</citation>
    <PMID>19021638</PMID>
  </results_reference>
  <results_reference>
    <citation>Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11703-8. doi: 10.1073/pnas.0903449106. Epub 2009 Jun 30.</citation>
    <PMID>19567835</PMID>
  </results_reference>
  <results_reference>
    <citation>Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendonça BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, Seminara SB. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab. 2010 Jun;95(6):2857-67. doi: 10.1210/jc.2009-2320. Epub 2010 Mar 23.</citation>
    <PMID>20332248</PMID>
  </results_reference>
  <results_reference>
    <citation>Sykiotis GP, Pitteloud N, Seminara SB, Kaiser UB, Crowley WF Jr. Deciphering genetic disease in the genomic era: the model of GnRH deficiency. Sci Transl Med. 2010 May 19;2(32):32rv2. doi: 10.1126/scitranslmed.3000288. Review.</citation>
    <PMID>20484732</PMID>
  </results_reference>
  <results_reference>
    <citation>Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, Seminara SB, Crowley WF Jr, Pitteloud N. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15140-4. doi: 10.1073/pnas.1009622107. Epub 2010 Aug 9.</citation>
    <PMID>20696889</PMID>
  </results_reference>
  <results_reference>
    <citation>Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, Kaiser UB, Seminara SB, Pitteloud N, Zhou QY, Crowley WF Jr. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations. Endocr Rev. 2011 Apr;32(2):225-46. doi: 10.1210/er.2010-0007. Epub 2010 Oct 29. Review.</citation>
    <PMID>21037178</PMID>
  </results_reference>
  <results_reference>
    <citation>Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, Hughes VA, Dwyer AA, Martin KA, Quinton R, Mericq V, Merino PM, Gusella JF, Crowley WF Jr, Pitteloud N, Hall JE. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011 Mar;96(3):E566-76. doi: 10.1210/jc.2010-2292. Epub 2011 Jan 5.</citation>
    <PMID>21209029</PMID>
  </results_reference>
  <results_reference>
    <citation>Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley WF Jr, Martin KA, Hall JE, Pitteloud N. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011 Jan 20;364(3):215-25. doi: 10.1056/NEJMoa0911064.</citation>
    <PMID>21247312</PMID>
  </results_reference>
  <results_reference>
    <citation>Tornberg J, Sykiotis GP, Keefe K, Plummer L, Hoang X, Hall JE, Quinton R, Seminara SB, Hughes V, Van Vliet G, Van Uum S, Crowley WF, Habuchi H, Kimata K, Pitteloud N, Bülow HE. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11524-9. doi: 10.1073/pnas.1102284108. Epub 2011 Jun 23.</citation>
    <PMID>21700882</PMID>
  </results_reference>
  <results_reference>
    <citation>Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, Au MG, Doty RL, Seminara SB, Chan YM, Pitteloud N, Crowley WF Jr, Balasubramanian R. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab. 2012 Jan;97(1):E136-44. doi: 10.1210/jc.2011-2041. Epub 2011 Nov 9.</citation>
    <PMID>22072740</PMID>
  </results_reference>
  <results_reference>
    <citation>Gianetti E, Hall JE, Au MG, Kaiser UB, Quinton R, Stewart JA, Metzger DL, Pitteloud N, Mericq V, Merino PM, Levitsky LL, Izatt L, Lang-Muritano M, Fujimoto VY, Dluhy RG, Chase ML, Crowley WF Jr, Plummer L, Seminara SB. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR). J Clin Endocrinol Metab. 2012 Sep;97(9):E1798-807. doi: 10.1210/jc.2012-1264. Epub 2012 Jun 28.</citation>
    <PMID>22745237</PMID>
  </results_reference>
  <results_reference>
    <citation>Avbelj Stefanija M, Jeanpierre M, Sykiotis GP, Young J, Quinton R, Abreu AP, Plummer L, Au MG, Balasubramanian R, Dwyer AA, Florez JC, Cheetham T, Pearce SH, Purushothaman R, Schinzel A, Pugeat M, Jacobson-Dickman EE, Ten S, Latronico AC, Gusella JF, Dode C, Crowley WF Jr, Pitteloud N. An ancient founder mutation in PROKR2 impairs human reproduction. Hum Mol Genet. 2012 Oct 1;21(19):4314-24. doi: 10.1093/hmg/dds264. Epub 2012 Jul 5.</citation>
    <PMID>22773735</PMID>
  </results_reference>
  <results_reference>
    <citation>Chew S, Balasubramanian R, Chan WM, Kang PB, Andrews C, Webb BD, MacKinnon SE, Oystreck DT, Rankin J, Crawford TO, Geraghty M, Pomeroy SL, Crowley WF Jr, Jabs EW, Hunter DG, Grant PE, Engle EC. A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain. 2013 Feb;136(Pt 2):522-35. doi: 10.1093/brain/aws345. Epub 2013 Jan 31.</citation>
    <PMID>23378218</PMID>
  </results_reference>
  <results_reference>
    <citation>Costa-Barbosa FA, Balasubramanian R, Keefe KW, Shaw ND, Al-Tassan N, Plummer L, Dwyer AA, Buck CL, Choi JH, Seminara SB, Quinton R, Monies D, Meyer B, Hall JE, Pitteloud N, Crowley WF Jr. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013 May;98(5):E943-53. doi: 10.1210/jc.2012-4116. Epub 2013 Mar 26.</citation>
    <PMID>23533228</PMID>
  </results_reference>
  <results_reference>
    <citation>Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF Jr, Seminara SB, Quinton R, Hughes VA, Kumanov P, Young J, Yialamas MA, Hall JE, Van Vliet G, Chanoine JP, Rubenstein J, Mohammadi M, Tsai PS, Sidis Y, Lage K, Pitteloud N. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013 May 2;92(5):725-43. doi: 10.1016/j.ajhg.2013.04.008.</citation>
    <PMID>23643382</PMID>
  </results_reference>
  <results_reference>
    <citation>Salian-Mehta S, Xu M, Knox AJ, Plummer L, Slavov D, Taylor M, Bevers S, Hodges RS, Crowley WF Jr, Wierman ME. Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2014 Apr;99(4):1452-60. doi: 10.1210/jc.2013-3426. Epub 2014 Jan 29.</citation>
    <PMID>24476074</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2007</study_first_submitted>
  <study_first_submitted_qc>June 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2007</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard University</investigator_affiliation>
    <investigator_full_name>William F. Crowley, Jr., M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Idiopathic Hypogonadotropic Hypogonadism</keyword>
  <keyword>Kallmann Syndrome</keyword>
  <keyword>Puberty</keyword>
  <keyword>Pituitary Abnormalities</keyword>
  <keyword>Hypothalamus</keyword>
  <keyword>anosmia</keyword>
  <keyword>GnRH deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Amenorrhea</mesh_term>
    <mesh_term>Kallmann Syndrome</mesh_term>
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Puberty, Precocious</mesh_term>
    <mesh_term>Puberty, Delayed</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

